In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...

This article explores the complex roles of cytokine networks in the development and progression of autoimmune diseases.

Azacitidine shows promising effectiveness and favorable glucocorticoid-sparing effects in patients with genetically confirmed ...

The Food and Drug Administration (FDA) has added more medicines for cancer, diabetes, high cholesterol, hypertension, and ...

Please provide your email address to receive an email when new articles are posted on . On the evening of Nov. 19, the FDA issued an emergency use authorization for the rheumatoid arthritis drug ...

AnaptysBio, Inc.'s rosnilimab shows promise in RA & ulcerative colitis, targeting $20B+ markets. Phase 2b results highlight its potential. Click for my ANAB update.

The Food and Drug Administration  has added 10 products to the list of essential medicines exempted from value-added tax  as ...

Which of the statements about the updated EULAR recommendations for antirheumatic drug use in reproduction, pregnancy, and lactation are correct?

Janus kinase (JAK) inhibitors are not associated with an increased risk for gastrointestinal perforation (GIP) among patients with rheumatoid arthritis (RA), according to study results published in ...

TEN additional health products have been exempted from the value-added tax (VAT) and are now more accessible to the public. Based on Advisory No. 2025-0510, the ...

The approval of baricitinib and abrocitinib has also been extended to include use in children and adolescents aged 2 years and older and adolescents aged 12 years and older, respectively. The strength ...